Therapy with low dose methotrexate plus diprospan in patient with recalcitrant recidivating sarcoidosis

O. S. Tolokh, J. E. Kulytka (Lviv, Ukraine)

Source: Annual Congress 2006 - Sarcoidosis
Session: Sarcoidosis
Session type: Electronic Poster Discussion
Number: 3127
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. S. Tolokh, J. E. Kulytka (Lviv, Ukraine). Therapy with low dose methotrexate plus diprospan in patient with recalcitrant recidivating sarcoidosis. Eur Respir J 2006; 28: Suppl. 50, 3127

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy and toxicity of azathioprine plus corticosteroids in 32 patients with chronic persistent sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004

Azathioprine and low-dose prednisone in chronic pulmonary sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 268s
Year: 2005

Treatment results using low doses of prednisolone, cyclophosphamide and extracorporeal processing of lymphocytes with prednisolone in patients with idiopathic interstitial pneumonia (IIP)
Source: Eur Respir J 2003; 22: Suppl. 45, 197s
Year: 2003

Combined cytotoxic treatment (methotrexate and cyclophosphamide) in association with prednisone in sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 713s
Year: 2004

Methotrexate vs azathioprine in chronic sarcoidosis
Source: Annual Congress 2012 - Sarcoidosis
Year: 2012

Synchronized therapy and high dose cyclophosphamide in lupus pneumonitis
Source: Eur Respir J 2004; 24: Suppl. 48, 506s
Year: 2004

High-doses glucocorticosteroid treatment in sarcoidosis patients
Source: Eur Respir J 2007; 30: Suppl. 51, 118s
Year: 2007

Combination of pentoxifylline and steroids in sarcoidosis treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 269s
Year: 2005

Methotrexate as a single agent for the treatment of patients with progressive pulmonary sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015


Infliximab in patients with refractory sarcoidosis: Trough concentrations of infiximab
Source: International Congress 2015 – Clinical problems in acute and chronic lung diseases
Year: 2015

Idiopathic pulmonary fibrosis: efficacy of complex immunosuppressive therapy by cyclophosphamide and corticosteroids
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009

The course of COVID-19 in pulmonary sarcoidosis patients, receiving methotrexate
Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis
Year: 2021


Combination treatment with nintedanib and prednisolone for patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018

Long-term response to prednisone in newly treated patients with pulmonary sarcoidosis
Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys
Year: 2021



Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab
Source: International Congress 2016 – Sarcoidosis
Year: 2016

Colchicine, prednisone versus no therapy in idiopathic pulmonary fibosis
Source: Eur Respir J 2006; 28: Suppl. 50, 744s
Year: 2006

High pulse dose steroids in Severe COVID-19 pneumonitis refractory hypoxemia to dexamethasone
Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment
Year: 2021



Sarcoidosis relapses in corticosteroid treated patients
Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura
Year: 2012



A 12-week combination of clarithromycin and prednisone for the treatment of cryptogenic and radiation-induced organising pneumonia
Source: International Congress 2015 – New insights into IIPs
Year: 2015

Late Breaking Abstract - Efficacy of oral prednisolone in patients with stable severe eosinophilic asthma (SEA) treated with Mepolizumab
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020